SAN RAMON, Calif.—Eyecare professionals (ECPs) anticipate an increase in the number of patient-facing discussions, prescriptions, and treatment options for myopia management over the next 10 to 20 years, according to a recent survey conducted by CooperVision Specialty EyeCare. The company invited ECPs from across the world to share their thoughts, hopes and predictions about the future of myopia management. The survey was conducted in celebration and recognition of the 20th anniversary of the FDA’s approval of Paragon CRT, the world’s first Ortho-K lens of its kind approved for safe overnight wear. Read More